🔴 First Tracks Biotherapeutics is trading 5% down in pre-market amid broader-market weakness

First Tracks Biotherapeutics is trading at $34.50 (-5.32%) amid a weak broader-market backdrop.

• No clear company-specific announcement for September 14, 2026 was identified; recent coverage centers on investor conferences and pipeline discussions.
• Nasdaq futures are down 1.54%, while S&P 500 futures are down 0.66%.
• First Tracks Biotherapeutics has also fallen over the past several sessions, suggesting continued risk-off pressure.